eCite Digital Repository

Effects of vitamin D supplementation on disabling foot pain in patients with symptomatic knee osteoarthritis

Citation

Tu, L and Zheng, S and Cicuttini, F and Jin, X and Han, W and Zhu, Z and Antony, B and Winzenberg, T and Jones, G and Gu, J and Wluka, AE and Ding, C, Effects of vitamin D supplementation on disabling foot pain in patients with symptomatic knee osteoarthritis, Arthritis Care & Research Article online ahead of print. ISSN 2151-464X (2020) [Refereed Article]


Preview
PDF (Accepted article)
Available from 06 December 2021
742Kb
  

Copyright Statement

This is the peer reviewed version of the following article, which has been published in final form at http://dx.doi.org/10.1002/acr.24371. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.

DOI: doi:10.1002/acr.24371

Abstract

Objectives: This study aims to determine whether vitamin D supplementation or maintaining sufficient vitamin D level reduces foot pain over two years in patients with symptomatic knee OA.

Methods: A post hoc study was conducted from a randomized double-blind placebo-controlled trial named the VItamin D Effect on Osteoarthritis (VIDEO) study. Symptomatic knee OA patients with serum 25-hydroxyvitamin D levels between 12.5 nmol/L to 60 nmol/L were included and randomly allocated to either monthly vitamin D3 or placebo treatment (1:1) for 2 years. Manchester Foot Pain and Disability Index (MFPDI) was used to evaluate foot pain and Disabling foot pain was defined as at least one of the 10 functional limitation items (items 1-9,11) being documented as on 'most/every day(s)' in the last month. A repeated-measure mixed effect model was used to analyze the change of MFPDI scores between groups adjusting for potential confounders.

Results: A total of 413 patients with a mean age of 63.2 years (49.7% males) were enrolled and 340 completed the study. The mean MFPDI score was 22.87.3, with 23.7% participants having disabling foot pain at baseline. There were significant differences in MFPDI scores change between groups over 2 years, with more improvements in vitamin D group than in placebo group (-0.03 vs. 1.30, P=0.013) and more improvement in those maintaining sufficient vitamin D levels (n=226) than those who did not (n=114) (-0.09 vs. 2.19, P=0.001).

Conclusion: Vitamin D supplementation and maintenance of sufficient vitamin D levels may improve foot pain in those with knee OA.

Item Details

Item Type:Refereed Article
Keywords:osteoarthritis, foot pain, vitamin D
Research Division:Biomedical and Clinical Sciences
Research Group:Clinical sciences
Research Field:Rheumatology and arthritis
Objective Division:Health
Objective Group:Clinical health
Objective Field:Clinical health not elsewhere classified
UTAS Author:Zheng, S (Miss Shuang Zheng)
UTAS Author:Jin, X (Mr Xingzhong Jin)
UTAS Author:Han, W (Dr Weiyu Han)
UTAS Author:Zhu, Z (Mr Zhaohua Zhu)
UTAS Author:Antony, B (Dr Benny Eathakkattu Antony)
UTAS Author:Winzenberg, T (Professor Tania Winzenberg)
UTAS Author:Jones, G (Professor Graeme Jones)
UTAS Author:Ding, C (Professor Chang-Hai Ding)
ID Code:141722
Year Published:2020
Web of Science® Times Cited:1
Deposited By:Menzies Institute for Medical Research
Deposited On:2020-11-12
Last Modified:2021-04-07
Downloads:0

Repository Staff Only: item control page